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Summary Alterations in hypothalamic—pituitary—adrenal (HPA)-axis activity and fatty acid
(FA)-metabolism have been observed in (recurrent) major depressive disorder (MDD). Through the
pathophysiological roles of FAs in the brain and cardiovascular system, a hypothesized relationship
between HPA-axis activity and FA-metabolism could form a possible missing link accounting for the
association of HPA-axis hyperactivity with recurrence and cardiovascular disease in MDD.
In 137 recurrent MDD-patients and 73 age- and sex-matched controls, we therefore investi-
gated associations between salivary cortisol (morning and evening) and the following indicators of
FA-metabolism measured in the red blood cell membrane: (I) three main FAs [eicosapentaenoic
acid (EPA), docosahexaenoic acid (DHA), and arachidonic acid (AA)], and (II) structural FA indices
(unsaturation, chain length, peroxidation) calculated from concentrations of 29 FAs to delineate
overall FA-characteristics. In addition, we compared these associations in patients with those in
controls.
In patients, evening cortisol concentrations were significantly negatively associated with DHA
(B = 1.358; SE = 0.499; t = 2.72; p = .006), the unsaturation index (B = 0.021; SE = 0.009;
t = 2.42; p = .018), chain length index (B = 0.060; SE = 0.025; t = 2.41; p = .019), and peroxi-
dation index (B = 0.029; SE = 0.012; t = 2.48; p = .015). The relations between cortisol and the
latter three variables were significantly negative in patients relative to controls. Significance
remained after correction for confounders.
Our results suggest a relationship between HPA-axis activity and FA-metabolism in recurrent
MDD. Future randomized experimental intervention studies using clinical outcome measures could
help to further elucidate the suggested effects of hypercortisolemia in the brain and cardiovas-
cular system in recurrent MDD.
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Major depressive disorder (MDD) accounts for an overwhelm-
ing global burden of disease. This is mainly due to its (I)
lifelong recurrent nature (Greden, 2001), and (II) association
with cardiovascular comorbidity (Charlson et al., 2011). Yet,
pathophysiological pathways underlying the recurrent nature
of MDD and its association with cardiovascular disease remain
unclear. A potential missing link could be a relationship
between hypothalamic—pituitary—adrenal (HPA)-axis activ-
ity and fatty acid (FA)-metabolism.
The HPA-axis is the principal endocrinological stress axis,
with the glucocorticoid hormone cortisol as the primary end
product of its activation. Although mixed results exist, the
extensive literature on cortisol in MDD mainly shows that
MDD-patients exhibit higher cortisol concentrations than
healthy controls (Stetler and Miller, 2011; Herbert, 2012),
both during MDD-episodes and in remission, suggesting an
endophenotype (Lok et al., 2011).
This hypercortisolemic trait has been proposed to
contribute to the development of both MDD-episodes
and cardiovascular disease in MDD. Specifically, hypercor-
tisolemia predicts the development of a first MDD-episode
in subjects at risk (Goodyer et al., 2000), as well
as recurrent episodes in remitted MDD-patients
(Appelhof et al., 2006), possibly through the effects of
excess cortisol on the brain, particularly the hippocampus
(Sapolsky, 2000; Kronmu¨ller et al., 2008; Ursache et al.,
2012). However, mixed results have also been observed
(Bockting et al., 2012). In addition, hypercortisolemia is
predictive of prospective death from cardiovascular dis-
ease in MDD-patients (Jokinen and Nordstro¨m, 2009).
Nevertheless, the precise (patho)physiological pathways
underlying the origin of hypercortisolemia and these asso-
ciations with recurrence and cardiovascular disease in MDD
remain unclear.
As for the HPA-axis, disturbed FA-metabolism has been
consistently reported in MDD (Assies et al., 2010; Lin et al.,
2010; Yager et al., 2010), both in acutely depressed and
remitted patients (Assies et al., 2010). Main findings are
lower concentrations of v3 long chain polyunsaturated fatty
acids (LCPUFA) [e.g. eicosapentaenoic acid (C20:5v3; EPA)
and docosahexaenoic acid (C20:6v3; DHA)] (Assies et al.,
2010; Lin et al., 2010), and decreased overall FA unsatura-
tion, chain length and peroxidizability (Mocking et al.,
2012b).
FAs have important structural and functional (patho)phy-
siological roles in both the nervous and cardiovascular system
(Piomelli et al., 2007; Mozaffarian and Wu, 2011; McNamara,
in press; Samieri et al., 2012). Structurally, FAs are major
components of (neuronal) membranes (Piomelli et al., 2007).
Unsaturation and chain length of membrane FAs determine
membrane fluidity, which on its turn influences functioning of
membrane bound proteins, e.g. neurotransmitter receptors
and cardiac ion channels (Piomelli et al., 2007). Moreover,
membrane FA peroxidizability determines membrane sus-
ceptibility to oxidative stress (Mocking et al., 2012b). Func-
tionally, FAs [particularly EPA, DHA and arachidonic acid
(C20:4v6; AA)] are involved in inflammatory regulation (Hib-
beln and Salem, 1995; Mozaffarian and Wu, 2011), and
maintenance of brain cytoarchitecture (Rao et al., 2006;
McNamara, in press).Previous studies have found a modulating effect of HPA-
axis activity on FA-metabolism. Cortisol influences mobili-
zation (Conner et al., 1996; Brenner et al., 2001; Macfar-
lane et al., 2008), lipolysis (Brenner et al., 2001),
oxidation (Hibbeln and Salem, 1995; Flerov et al.,
2003), and synthesis (Hibbeln and Salem, 1995; Brenner
et al., 2001) of FAs. For example, cortisol inhibits D5- and
D6-desaturase-activity (de Alaniz and Marra, 2003),
enzymes responsible for unsaturation of FA chains. In
addition, oxidative stress associated with hypercortisole-
mia (Sato et al., 2010) could influence FA concentrations
(Hibbeln and Salem, 1995; Flerov et al., 2003; Yager et al.,
2010). These influences seem to have differential effects
on specific FAs (Hibbeln and Salem, 1995; Conner et al.,
1996; de Alaniz and Marra, 2003; Gounarides et al., 2008),
in such a way that high cortisol concentrations are asso-
ciated with a decrease in v3 LCPUFA concentrations and FA
unsaturation, chain length and peroxidizability.
Vice versa, FAs also seem to affect the HPA-axis (Lan-
franco et al., 2004). Dietary supplementation of v3 LCPUFA
(e.g. EPA) reduced cortisol concentrations in rats (Song
et al., 2003), healthy subjects (Delarue et al., 2003), and
MDD-patients (Jazayeri et al., 2010; Mocking et al.,
2012a). In addition, a maternal preweaning v3 PUFA defi-
cient diet induces HPA-axis hyperactivity in rat offspring
(Chen and Su, 2012). Furthermore, in chronically stressed
monkeys, the v6/v3 ratio was positively associated with
cortisol response to acute stress (Laugero et al., 2011).
Supplementation of v3 LCPUFA increases concentrations of
EPA and DHA (polyunsaturated FAs with a long chain
length), and decreases concentrations of AA. These FA-
alterations may alter the feedback of the HPA-axis in three
ways: (I) FAs influence glucocorticoid receptor functioning,
depending on their degree of unsaturation and chain length
(Vallette et al., 1991), (II) EPA and AA modulate p-glyco-
protein function and thereby cortisol transport across the
blood—brain barrier (Murck et al., 2004), and (III) the AA/
EPA ratio regulates production of pro- or anti-inflammatory
eicosanoids, which can influence HPA-axis activation [via
corticotrophin releasing hormone (CRH) secretion] and
feedback (through induction of glucocorticoid receptor
resistance) (Hibbeln and Salem, 1995; Schiepers et al.,
2005).
Based on this literature, a relationship between the HPA-
axis and FA-metabolism can be expected. Through the effects
of FAs in the brain and cardiovascular system, this relation-
ship might play an important role in the reinforcement and
explanation of recurrence and cardiovascular disease in
recurrent MDD.
However, the association between cortisol and FA-meta-
bolism has never been investigated in MDD, especially not in
comparison with controls. Therefore, we aimed to study the
supposed relationship between HPA-axis activity and FA-
metabolism in MDD by testing the associations between
cortisol and FA-concentrations in patients with recurrent
MDD and matched controls. We hypothesized that cortisol
would be negatively associated with (I) concentrations of v3
LCPUFAs (e.g. EPA and DHA), and (II) indicators of overall FA-
metabolism (e.g. unsaturation, chain length and peroxidiz-
ability). In addition, we hypothesized that these associations
would be more negative in patients with recurrent MDD than
in controls.
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2.1. Participants
Recruitment of the study population has been described in
more detail previously (Assies et al., 2010; Lok et al., 2011).
In brief, we initially recruited patients at psychiatric centers
and through media announcements for participation in a
randomized controlled trial investigating the effect of eight
weekly group sessions of cognitive therapy vs. naturalistic
care on recurrence in patients with recurrent MDD. Inclusion
criteria of the original trial were: 2 previous MDD-episodes
in the last 5 years, as defined by the Structured Clinical
Interview for DSM-IV disorders (SCID) (First et al., 1996); in
remission >10 weeks and <2 years, as defined by a score < 10
on the 17-item Hamilton Depression Rating Scale (HDRS17)
(Hamilton, 1960); and 18—65 years old. Exclusion criteria
were: (a history of) bipolar spectrum disorder or any psy-
chotic disorder, organic brain damage, alcohol and/or drug
abuse and/or dependency, or predominant anxiety disorder,
all assessed by the SCID.
For the present study, we invited patients at 2 years
follow-up of the original trial. Thereby, we aimed to recruit
a homogeneous sample of patients with an endogenous bio-
logical vulnerability for recurrent MDD and cardiovascular
comorbidity (Greden, 2001). We did not exclude patients
based on depressive status or medication (e.g. antidepres-
sants) use, because previously, both FA-metabolism and HPA-
axis activity were not substantially influenced by these fac-
tors in this population (Assies et al., 2010; Lok et al., 2011).
In addition, we recruited controls through media-adver-
tisements, matched for sex and age using strata based on
gender and 5-year age groups. We excluded controls with a
current or past (personal and/or family) history of psychiatric
DSM-IV axis-I disorders, as assessed by the SCID.
The medical ethical committee of the Academic Medical
Center of the University of Amsterdam approved the study
protocol, and all participants provided written informed
consent.
2.2. Measures
To correct for potential confounders, we asked subjects for
marital status, educational level, social class, smoking beha-
vior, and calculated their body mass index (BMI; weight/
length2). We operationalized smoking dichotomously (yes/
no), and educational level in three classes: low (primary
education or preparatory middle-level applied education),
middle (higher general continued education or middle-level
applied education) and high (preparatory scientific educa-
tion, higher applied education or scientific education). Simi-
larly, we distinguished three social classes, based on
occupation: Class 1, e.g. cleaner; Class 2, e.g. nurse; Class
3, e.g. general manager, as described previously (Lok et al.,
2011). We measured depressive symptoms in all subjects
using the HDRS17 (Hamilton, 1960).
2.2.1. HPA-axis
For the HPA-axis, we measured concentrations of cortisol,
expressed in nmol/ml, using radioimmunoassays (IBL Ham-
burg; designed for saliva samples; intra- and interassayvariations: 5.1% and 6.5%, respectively) on saliva collected
in neutral cotton salivettes (Sarstedt AG and Co, Nu¨mbrecht,
Germany) (Lok et al., 2011), which provides a stress free,
minimally intrusive, and reliable reflection of blood cortisol
concentrations. We instructed subjects to collect saliva at
home at three sampling moments on two consecutive days
(day one: 0800 h and 2200 h; day two: 0800 h), after rinsing
their mouths with water and not having brushed their teeth.
Subjects collected morning samples after an overnight fast,
and kept all samples refrigerated until sending them back by
mail to the clinic on day two, where we stored samples at
20 8C until analysis. For analyses, we averaged the two
subsequent morning (0800 h) cortisol values into one morning
cortisol value (Lok et al., 2011). Both averaged morning and
evening cortisol were normally distributed after log trans-
formation.
2.2.2. FA-metabolism
We used washed erythrocyte FA-concentrations as a model of
brain FA-concentrations. From blood, sampled in the non-
fasting state, we separated and washed erythrocytes and
stored them at 80 8C until analyses by capillary gas chro-
matography, as described previously (Assies et al., 2010). We
expressed concentrations of 29 different FAs in pmol/106
erythrocytes. To analyze the association between HPA-axis
activity and overall FA-metabolism, we calculated three
indices that delineate main structural FA-characteristics on
the basis of all 29 FA-concentrations (Mocking et al., 2012b).
The (I) unsaturation index (UI) denotes the mean number of
double bounds per FA; (II) chain length index (CLI), provides
information about the mean number of carbon atoms per FA;
and (III) peroxidation index (PI), delineates the mean FA
susceptibility to oxidative stress.
2.3. Statistical analyses
To (I) prevent bias possibly introduced by missing values, and
(II) facilitate calculation of indices — despite non-detectable
FA in individual patients — and thereby remaining adequate
power, we used multiple imputation, as described previously
(Lok et al., 2011; Mocking et al., 2012b). Simulation research
has shown that multiple imputation effectively reduces bias
potentially introduced by missing values, not by estimating
these missing values themselves, but by providing highly valid
estimations of effects parameters in a model based on partly
missing data. As opposed to most other imputation techni-
ques, it does include the uncertainty in the estimation of
these effect parameters using a random term. By doing so,
the estimation of the effect parameters is penalized through
correction (increase) of the standard errors for the variance
between the multiple imputation datasets (Donders et al.,
2006). Multiple imputation is also reported to perform very
well in small samples (n = 50), even with large multiple
regression models (as large as 18 predictors) and even when
as much as 50% of data in the dependent variable is missing
(Graham, 2009).
In our study, in brief, 28.1%, 29.5%, 29.0%, 14.3%, 13.8% and
14.3% of the two morning and evening cortisol, EPA, DHA and
AA values, respectively, were missing or non-detectable. As
reported previously (Lok et al., 2011; Mocking et al., 2012b),
we used Amelia II (http://www.gking.harvard.edu/amelia/),
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impute missing values. In this process we incorporated vari-
ables that are known to, or were observed to, be associated
with the variables which had missing values. Specifically, we
included sex, age, marital status, educational level, social
class, HDRS17 score, weight, length, waist and hip circumfer-
ence, smoking, and salivary cortisol and dehydroepiandroster-
one sulphate, folic acid, vitamin B6and B12, homocysteine, and
all other measured FA-concentrations in our imputation
model. Although Amelia II performs relatively well with
non-normally distributed variables, we transformed non-nor-
mally distributed and categorical/ordinal variables as indi-
cated by the program. In addition, for non-detectable values,
we assigned range priors in Amelia II that indicate that a non-
detectable FA concentration must lie between 0.001 and the
detection limit of that FA (with 99% confidence) (Mocking
et al., 2012b). We used standard diagnostics available in
Amelia II to check the imputation results, and observed no
potential problems, e.g. induced by deviations from normal
distribution.
To compare patients’ and controls’ basic characteristics,
we used independent-samples t-tests and x2-tests. We addi-
tionally implemented multiple regression models, with morn-
ing or evening cortisol as independent variable and the FA or
index as outcome variable. We corrected for confounders,
selected a priori, by adding relevant variables (sex, age,
marital status, educational level, social class, HDRS17-score,
BMI and smoking) as predictors to the model. In addition,
although FA- and cortisol concentrations were not substan-
tially influenced by antidepressant use or depressive state in
this population (Assies et al., 2010; Lok et al., 2011), effects
of these variables have been reported. Therefore, we addi-
tionally included depressive state (yes/no) and antidepres-
sant use (yes/no) as predictors in the patient models.
Moreover, since particularly tricyclic antidepressants (TCAs)
have been reported to influence the HPA-axis, we conducted
additional sensitivity analyses in which we excluded TCA
users from the analyses. To investigate the differences in
HPA-axis—FA-metabolism associations between patients and
controls, we used another set of regression analyses. These
regression models additionally included [next to the group
variable and the appropriate HPA-axis variable (morning or
evening)] a group  HPA-axis (morning and evening in sepa-
rate models) interaction in the model as an independent
variable, with the different FA-metabolism variables as out-
come variables. Finally, to provide an impression of the
effects of multiple imputation on the analyses, we addition-
ally performed the analyses without using multiple imputa-
tion, represented in Tables S1—S3.
3. Results
3.1. Participant characteristics
One hundred and thirty-seven patients and 73 controls were
included in this study. Table 1 shows characteristics of
patients and controls. Matching for age and sex was success-
ful, although patients differed on some demographic vari-
ables (lower educational level and social class in the patient
group). Morning and evening cortisol values corresponded
with a hyperactive HPA-axis in the patients. In addition,patients had a disturbed FA-metabolism, reflected by both
lower concentrations of EPA, DHA and AA and lower FA-
indices (Assies et al., 2010; Lok et al., 2011; Mocking
et al., 2012b).
3.2. Association between HPA-axis and FAs in
patients
Table 2 shows results of linear regression models of associa-
tions between morning and evening cortisol and FA-concen-
trations and -indices in patients. All indices and DHA (Fig. 1)
were negatively associated with evening cortisol concentra-
tions (.006  p  .019); significance remained after correc-
tion for possible confounders (.003  p  .023), and after
exclusion of TCA users. This indicates that more pronounced
evening hypercortisolemia was associated with lower con-
centrations of the v3 LCPUFA DHA and decreased overall FA
unsaturation, chain length and peroxidizability. Morning cor-
tisol concentrations were not significantly associated with
FA-metabolism. Results without multiple imputation are pro-
vided in Table S1.
3.3. Association between HPA-axis and FAs in
controls
Table 3 shows results of linear regression models of associa-
tions between morning and evening cortisol and FA-concen-
trations and -indices in controls. Morning cortisol was
positively associated with AA at trend level ( p = .059), other
associations between cortisol and FA-metabolism were not
significant (.518  p  .985; Table 3). Results without multi-
ple imputation are provided in Table S2.
3.4. Differences between patients and controls
in the association between HPA-axis and FAs
The group  evening cortisol interaction-term was signifi-
cant for the UI, CLI and PI (.024  p  .032; Table 4;
Fig. 2). Associations between evening cortisol concentrations
and index measures were significantly negative in patients
relative to controls. This indicates that higher evening cor-
tisol concentrations were associated with greater decreases
in overall FA unsaturation, chain length and peroxidizability
in patients relative to controls. These differences remained
after correction for confounders (.034  p  .049). Results
remained significant after exclusion of TCA users, except for
the corrected effect of the group  evening cortisol inter-
action regarding the PI ( p = .063). The group  evening cor-
tisol interaction-term was not significant for the individual
FA-concentrations ( p > .127). The group  morning cortisol
interaction was not significant for any of the indicators of FA-
metabolism. Results without multiple imputation are pro-
vided in Table S3.
4. Discussion
In this study, we investigate the relationship between HPA-
axis activity and FA-metabolism in recurrent MDD by testing
associations between cortisol and FA-concentrations in 137
patients with 2 previous MDD-episodes and comparing them
Table 1 Subject characteristics.
Characteristic Patients (n = 137) Controls (n = 73) p-Value
Female, % 73.7% 69.9% .55
Age, mean (SE), year 46.4 (0.8) 44.7 (1.1) .205
Educational levela, % <.001
Low 33.3 5.2
Middle 31.2 22.5
High 35.5 72.3
Social classb, % <.001
Class 1 11.1 55.0
Class 2 52.1 32.0
Class 3 36.7 13.0
Smoking, % 49.0 39.4 .21
Body mass index, mean (SE), kg/m2 26.0 (0.44) 24.8 (0.43) .062
HDRS17 score, mean (SE) 5.9 (.46) 1.2 (.48) <.001
Current depressive episode, % (n) 19.0 (26) NA
Antidepressant use, % (n) 62.8 (86) NA
TCA, % (n) 5.1 (7) NA
SSRI, % (n) 38.7 (53) NA
SNRI, % (n) 11.7 (16) NA
Lithium and SNRI or TCA, % (n) 3.0 (4) NA
Lithium, % (n) 0.7 (1) NA
Other, % (n) 3.7 (5) NA
Number of previous episodes, mean (SE) 7.71 (0.76) NA
Age of first onset, mean (SE), year 28.4 (1.08) NA
0800 h cortisolc,d, mean (SE), nmol/ml 3.70 (0.06) 3.44 (.08) .009
2200 h cortisold, mean (SE), nmol/ml 1.19 (0.07) .50 (.09) <.001
EPA, mean (SE), pmol/106 erythrocytes 3.35 (0.14) 3.91 (.23) <.001
DHA, mean (SE), pmol/106 erythrocytes 14.92 (0.45) 20.20 (.75) <.001
AA, mean (SE), pmol/106 erythrocytes 71.96 (0.74) 81.33 (1.0) <.001
UI, mean (SE) 1.29 (0.01) 1.39 (.01) <.001
CLI, mean (SE) 18.32 (0.02) 18.55 (.01) <.001
PI, mean (SE) 1.10 (0.01) 1.22 (.01) <.001
Abbreviations: HDRS, Hamilton depression rating scale; TCA, tricyclic antidepressant; SSRI, selective serotonin reuptake inhibitor; EPA,
eicosapentaenoic acid; DHA, docosahexaenoic acid; AA, arachidonic acid; UI, unsaturation index; CLI, chain length index; PI, peroxidation
index.
a Educational level is defined as: low, primary education or preparatory middle-level applied education; middle, higher general continued
education or middle-level applied education; and high, preparatory scientific education, higher applied education, or scientific education.
b Based on occupation: Class 1, e.g. cleaner; Class 2, e.g. nurse; Class 3, e.g. general manager.
c Averaged value over two values on two consecutive days.
d Log transformed.
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evening cortisol concentrations were significantly negatively
associated with the v3 LCPUFA DHA, and overall FA unsatura-
tion, chain length and peroxidizability in the patients.
Furthermore, we found that the associations of evening
cortisol with FA indices were significantly different in MDD-
patients versus controls (group  HPA-axis interaction), with
significantly negative associations in MDD-patients relative to
controls.
The associations between cortisol and DHA, FA-unsatura-
tion, chain length and peroxidizability underline the relation-
ship between functioning of the HPA-axis and FA-metabolism
in MDD. The association between DHA and cortisol is in line
with earlier clinical observations of associations between
DHA and indicators of HPA-axis activity: DHA was associated
with CRH in perpetrators of domestic violence (Hibbeln
et al., 2004), and 5a-dihydroprogesterone in patients diag-
nosed with either alcohol abuse, MDD, or both (Nieminen
et al., 2010).Studies that experimentally influenced this relationship
between HPA-axis activity and FA-metabolism by administra-
tion of FAs or glucocorticoids suggest that effects could
operate in two directions (Hibbeln and Salem, 1995; Delarue
et al., 2003): on the one hand, an effect of the HPA-axis on
FA-metabolism, and vice versa, an effect of FA-metabolism
on HPA-axis activity.
With regard to the effects of HPA-axis activity on FA-
metabolism, it may be that the endophenotypic hypercorti-
solemia observed in MDD-patients reduces synthesis and/or
incorporation of unsaturated long chain FAs (e.g. DHA) in the
cell membrane (Hibbeln and Salem, 1995; Brenner et al.,
2001; Flerov et al., 2003), resulting in altered FA metabolism
in MDD-patients. Indeed, decreased overall FA-peroxidizabil-
ity, -unsaturation, and -chain length have been observed in
MDD, with lower concentrations of the LCPUFAs EPA, DHA and
total v3 FAs in blood and brain tissue (Assies et al., 2010; Lin
et al., 2010; McNamara, 2010; Yager et al., 2010; Mocking
et al., 2012b). Initially, by decreasing membrane peroxidiz-
Table 2 Associations between morning and evening cortisol concentrations and fatty acid concentrations and indices, with and
without correction for several confounders, in 137 patients with recurrent depression (linear regression).
HPA-axis FA (n = 137) Uncorrected Correctedd
B (SE) t p B (SE) t p
0800 h cortisola,b EPAc 0.230 (0.294) .783 .446 0.020 (0.235) .085 .932
DHAc 0.071 (0.681) .104 .918 0.444 (0.697) .637 .526
AAc 0.031 (1.258) .024 .981 0.096 (1.524) .063 .950
UI 0.002 (0.010) 0.21 .837 0.010 (0.010) .938 .349
CLI 0.024 (0.026) .917 .359 0.037 (0.028) 1.35 .178
PI 0.005 (0.013) .359 .720 0.017 (0.014) 1.23 .220
2200 h cortisol b EPAc 0.234 (0.193) 1.22 .225 0.308 (0.177) 1.74 .083
DHAc 1.358 (0.499) 2.72 .006 1.567 (0.524) 2.99 .003
AAc 0.677 (1.136) 0.60 .555 0.469 (1.189) .395 .696
UI 0.021 (0.009) 2.42 .018 0.022 (0.009) 2.34 .022
CLI 0.060 (0.025) 2.41 .019 0.062 (0.024) 2.55 .012
PI 0.029 (0.012) 2.48 .015 0.029 (0.012) 2.34 .023
Abbreviations: HDRS, Hamilton depression rating scale; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; AA, arachidonic acid; UI,
unsaturation index; CLI, chain length index; PI, peroxidation index. Bold numbers indicate statistical significance.
a Average over two values on two consecutive days.
b nmol/ml, log transformed.
c pmol/106 erythrocytes.
d Corrected for sex, age, marital status, educational level, social class, HDRS17-score, body mass index, smoking, antidepressant use, and
depressive state.
1612 R.J.T. Mocking et al.ability, these FA-changes may (possibly adaptatively) protect
against hypercortisolemia induced oxidative stress. However,
the involved FAs have important functional and structural
roles in human (patho)physiology [e.g. cell membrane con-
stituents (Piomelli et al., 2007; McNamara, in press), inflam-
matory (Hibbeln and Salem, 1995) and cytoarchitecture
modulators (Rao et al., 2006)]. Hereby, the FA-alterations
may affect (I) functioning of membrane-bound neurotrans-
mitter receptors and gray and white matter integrity in the
brain (Piomelli et al., 2007; McNamara, in press); and (II)
triglyceride production, heart rate, myocardial efficiency,
blood pressure, vascular resistance, endothelial dysfunction,Figure 1 Relationship between cortisol and docosahexaenoic
acid concentrations in 137 patients with recurrent depression.
Lines represent linear fit lines and 95% confidence intervals. B
(SE) = 1.358 (0.499), t = 2.72, p = .006.and thrombosis, in the cardiovascular system (Mozaffarian
and Wu, 2011). Therefore, in the long term, these FA-changes
might very well affect the nervous [e.g. hippocampal neu-
ronal cell structure and function (Sapolsky, 2000; McNamara,
in press; Samieri et al., 2012)] and cardiovascular system
(atherosclerosis) (Yager et al., 2010; Mozaffarian and Wu,
2011). Thereby, these (patho)physiological mechanisms may
explain part of the increased risk for recurrence and/or
cardiovascular comorbidity in MDD (Harris, 2007; Kronmu¨ller
et al., 2008; Jokinen and Nordstro¨m, 2009; Yager et al., 2010;
Harris et al., in press; McNamara, in press; Ursache et al.,
2012).
With regard to the effects of FA-metabolism on HPA-axis
activity, the observed reduced FA unsaturation and chain
length in MDD-patients may have altered HPA-axis feedback
in MDD, due to their influence on glucocorticoid receptor and
p-glycoprotein functioning (Vallette et al., 1991; Murck et al.,
2004). Depending on degree of unsaturation and chain length,
FA modulate binding of glucocorticoids to the glucocorticoid
receptor, possible by inducing a conformational change (Vall-
ette et al., 1991; Sumida, 1995). Moreover, FAs have been
hypothesized to regulate activity of p-glycoprotein, which is
responsible for transport of cortisol across the blood—brain
barrier. FAs have been hypothesized to regulate p-glycoprotein
activity by modulating prostaglandin E2 concentrations (Murck
et al., 2004). In addition, research into cancer drug resistance
showed that PUFAs reduce gene expression, protein produc-
tion and pump activity of p-glycoprotein (Kuan et al., 2011).
Therefore, reduced p-glycoprotein activity resulting from FA-
alterations may lead to reduced transport of cortisol across the
blood—brain barrier. This reduced cortisol transport to the
brain may explain disturbances in HPA-axis feedback, which
have been hypothesized to form the main pathophysiological
mechanism underlying hypercortisolemia in MDD-patients
(Herbert, 2012). This way, FA-alterations could provide a
Table 3 Associations between morning and evening cortisol concentrations and fatty acid concentrations and indices, with and
without correction for several confounders, in 73 non-depressed controls (linear regression).
HPA-axis FA (n = 73) Uncorrected Correctedd
B (SE) t p B (SE) t p
0800 h cortisola,b EPAc 0.085 (0.373) .228 .820 0.262 (0.416) .631 .530
DHAc 0.461 (1.202) .383 .702 0.878 (1.358) .646 .518
AAc 2.168 (1.588) 1.37 .172 3.165 (1.669) 1.90 .059
UI 0.001 (0.009) 0.14 .886 0.001 (0.010) .116 .908
CLI 0.004 (0.018) .194 .846 0.004 (0.021) .173 .863
PI 0.008 (0.014) .597 .550 0.010 (0.015) .646 .518
2200 h cortisol b EPAc 0.152 (0.324) .470 .639 0.232 (0.327) .709 .478
DHAc 0.207 (1.034) .200 .841 0.022 (1.141) .019 .985
AAc 0.351 (1.410) .249 .803 0.755 (1.600) .472 .638
UI 0.007 (0.008) .866 .386 0.006 (0.009) .658 .511
CLI 0.011 (0.017) .666 .507 0.009 (0.020) .481 .632
PI 0.009 (0.012) .717 .474 0.006 (0.013) .414 .679
Abbreviations: HDRS, Hamilton depression rating scale; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; AA, arachidonic acid; UI,
unsaturation index; CLI, chain length index; PI, peroxidation index.
a Average over two values on two consecutive days.
b nmol/ml, log transformed.
c pmol/106 erythrocytes.
d Corrected for sex, age, marital status, educational level, social class, HDRS17-score, body mass index and smoking.
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recurrent MDD-patients.
These two directions of association provide three possible
causal mechanisms as explanation for the relationship
between HPA-axis activity and FA-metabolism, as observed
in this study. First, the effect of the HPA-axis on FA-meta-
bolism could be the primary cause of the relationship. Alter-
natively, the relationship could be explained by the effect of
FA-metabolism on the HPA-axis. Finally, effects could operateTable 4 Cortisol (morning, evening) by group [patients, n = 1
explaining fatty acid concentrations and indices, with and withou
HPA-axis FA Uncorrected 
B (SE) t 
0800 h cortisola,b EPAc 0.146 (0.473) .308
DHAc 0.531 (1.238) .429
AAc 2.199 (2.057) 1.07 
UI 0.001 (0.015) .049
CLI 0.020 (0.039) .520
PI 0.004 (0.021) .174
2200 h cortisol b EPAc 0.082 (0.341) .240
DHAc 1.565 (1.026) 1.53 
AAc 0.326 (1.813) .180
UI 0.028 (0.013) 2.25 
CLI 0.071 (0.033) 2.17 
PI 0.038 (0.017) 2.15 
Abbreviations: HDRS, Hamilton depression rating scale; EPA, eicosapent
unsaturation index; CLI, chain length index; PI, peroxidation index. Bo
a Average over two values on two consecutive days.
b nmol/ml, log transformed.
c pmol/106 erythrocytes.
d Corrected for sex, age, marital status, educational level, social clain both ways, i.e. a bidirectional relationship, given that
hypercortisolemia has been reported to induce these specific
FA-disturbances (Brenner et al., 2001; Flerov et al., 2003;
Piomelli et al., 2007; Sato et al., 2010), which on their turn
can influence HPA-axis hyperactivity (Vallette et al., 1991;
Delarue et al., 2003). In order to fully grasp the role of the
delicate balance between these two systems in homeostasis
and pathophysiology, further studies are warranted,
preferably using repeated measurements of cortisol and37; controls, n = 73 (reference category)] interaction-terms
t correction for confounders (linear regression).
Correctedd
p B (SE) t p
 .760 0.178 (0.411) .432 .666
 .668 0.355 (1.205) .295 .768
.287 1.937 (2.099) .923 .358
 .961 0.005 (0.016) .331 .741
 .603 0.023 (0.040) .579 .563
 .862 0.003 (0.022) .126 .900
 .811 0.002 (0.316) .007 .994
.127 1.530 (1.013) 1.51 .131
 .858 0.085 (1.808) 0.047 .963
.024 0.027 (0.013) 2.12 .035
.030 0.070 (0.033) 2.13 .034
.032 0.035 (0.018) 1.97 .049
aenoic acid; DHA, docosahexaenoic acid; AA, arachidonic acid; UI,
ld numbers indicate statistical significance.
ss, HDRS17-score, body mass index and smoking.
Figure 2 Relationships between cortisol and the unsaturation
index (UI), chain length index (CLI) and peroxidation index (PI)
compared between 137 recurrently depressed patients and 73
controls. Lines represent linear fit lines and 95% confidence
intervals. For UI: B (SE) = 0.028 (0.013), t = 2.25, p = .024;
for CLI: B (SE) = 0.071 (0.033), t = 2.17, p = .030; for PI: B
(SE) = 0.038 (0.017), t = 2.15, p = .032.
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tions aimed at the HPA-axis or FA-metabolism in selected
clinical samples (e.g. recurrent MDD patients).
Interestingly, our results do not show a significant rela-
tionship between morning cortisol concentrations and FA-
metabolism. This was also found in a study in healthy men, in
which evening cortisol was more pronouncedly associated
with metabolic effects than morning cortisol (Plat et al.,
1999). However, our morning cortisol values are based on two
subsequent morning values independent of awakening time,
instead of multiple morning measures reflecting the cortisol
awakening response. Therefore, it is possible that our sam-
pling-methods caused exogenous variability in the data,
which could consequently serve as an explanation for theabsence of an association between morning cortisol and FA-
metabolism. Nonetheless, it can also be argued that
increased evening cortisol concentrations (and the more
negative associations with FA-metabolism) reflect the main
pathophysiological HPA-axis disturbance in MDD, i.e. higher
baseline HPA-axis activity. Indeed, differences in cortisol
concentrations between patients and controls in our study
were more pronounced in the evening than in the morning.
On the other hand, although morning cortisol concentrations
were higher compared to controls, relatively lower morning
cortisol concentrations predicted recurrence in a patient
group remitted from recurrent MDD (Bockting et al.,
2012). A similar pattern was also seen in a recent study
which showed that in subjects who had been exposed to
early life stress, relative hypercortisolemia was associated
with less psychological distress, while a blunted cortisol
response was associated with recurrent psychological dis-
tress (Goldman-Mellor et al., 2012). This could suggest that
hypercortisolemia in a subgroup of patients (particularly
those who experienced early life stress) might represent
an adaptive phenomenon, possibly preventive against MDD-
recurrence (e.g. on the shorter-term). However, this could be
at the cost of hypercortisolemia associated perturbations in
FA-metabolism, potentially inducing elevated allostatic load
associated cardiovascular risk (e.g. on the longer-term; Fries
et al., 2005). In conclusion, the relevance of the mechanisms
underlying the differences in associations of morning versus
evening cortisol concentrations with FA-metabolism remains
to be further elucidated.
Some limitations need to be addressed further. First, the
observed relations could be a reflection of confounding
factors. Despite correction for e.g. educational level, social
class, anthropometric characteristics and smoking, we did
not correct for diet. The interest in the relationship between
MDD and FA-metabolism initially began with the observation
of a negative relationship between fatty fish intake and MDD
prevalence (Appleton et al., 2008). This may indicate that
diet could have had a confounding influence in our study.
However, more recently, some studies suggest relatively
small dietary influences on FA-concentrations (Assies
et al., 2010; Bentsen et al., 2011), as a result of strict
endogenous regulation. Furthermore, because of the asso-
ciations between demographic and anthropometric factors
and diet, correction for these factors may have already
reduced the influence of diet. Finally, stress is associated
with increased dietary preference for high-caloric, palatable
foods, which contain relatively more saturated FA and less
LCPUFAs. This may possibly alter physiological FA-concentra-
tions, in which case diet may be considered as a mediator of
the relationship between the HPA-axis and FA-metabolism,
instead of a confounder (Dallman et al., 2003; Groesz et al.,
2012). Interestingly, as a potential adaptive mechanism, this
altered dietary preference seems to attenuate HPA-axis
activity and associated behavior (Dallman et al., 2003).
However, the initially observed correlations between fish
intake and MDD were relatively strong; therefore, further
studies are needed to investigate whether dietary preference
acts as a confounder and/or a mediator of the observed
relation between HPA-axis activity and FA-metabolism.
Second, although we used multiple imputation to reduce
bias introduced by missing values, it could still have been that
missing values influenced our result. Multiple imputation is
Fatty acids and cortisol in depression 1615based upon the assumption that data are missing at random.
This means that missingness (i.e. whether data are missing or
not) may depend on observed data, but not on unobserved
data (Graham, 2009). In our study, we were able to include
several predictors in the imputation model (e.g. psycho-
pathological, demographic, and other biological variables),
which increases the change that missingness is accounted for
by observed data. In addition, most missing data in our study
is missing completely at random, e.g. due to laboratory or
logistic accidents, which in any case would not result in
biases (Donders et al., 2006). Furthermore, bias by missing
values would not easily explain the observed relations. Com-
paring results with and without multiple imputation should
be done with caution. In general, in the present study, effect
parameters without imputation had similar directions as
those after multiple imputation, with only modest differ-
ences between results with and without imputation for
individual FAs (Supplementary discussion). However, replica-
tion of our findings would strengthen the evidence.
Third, FA-analyses were performed on concentrations of
FAs from different subclasses combined, without differentia-
tion with regard to phospholipid class, e.g. phosphatidylcho-
line, sphingomyelin. This differentiation could have
produced more distinguished results and would be an inter-
esting addition in further research. Furthermore, future
research could benefit from inclusion of cholesterol concen-
trations in the analyses, given the interplay between the HPA-
axis, FA-metabolism, and cholesterol (Hibbeln and Salem,
1995; Mocking et al., 2012a). Fourth, sleep quality and time
of awaking were not included in the model, which could have
influenced HPA-axis activity and FA-metabolism (Irmisch
et al., 2007). Finally, no measures of HPA-axis feedback
(e.g. dexamethasone suppression test) were included in
the present study. Although the used methodology have been
previously shown to be able to adequately quantify differ-
ences in HPA-axis activity both between patients and controls
and different patient subclasses (Lok et al., 2011), it would
be an interesting option for future research to link alterations
in FA-metabolism to measures of HPA-axis feedback, espe-
cially considering the suggested association of FA-metabolism
with p-glycoprotein functioning (Murck et al., 2004).
Strengths of our study are the inclusion of highly recurrent
depressed patients as representatives of a more biologically
determined MDD-subtype, which may be specifically linked to
recurrence and cardiovascular co-morbidity. Therefore, the
included patient group can be considered characteristic for
those patients particularly causing the large MDD-associated
burden of disease. In addition, our study allowed for the
investigation of the relationship between cortisol and FA-
metabolism in MDD-patients in comparison with matched
controls. Our findings suggest HPA-axis and FA-metabolism
interactions as a (patho)physiological mechanism underlying
MDD recurrence and its association with cardiovascular dis-
ease, which first need replication. Thereafter, our findings
could provide new targets for treatments to prevent recur-
rence in MDD.
In conclusion, our results corroborate that HPA-axis activ-
ity is associated with FA-metabolism in recurrent MDD. More
specifically, evening cortisol concentrations are significantly
negatively associated with FA indices in recurrent MDD-
patients relative to controls. Future randomized experimen-
tal intervention studies using clinical outcome measurescould help to further elucidate the suggested effects of
hypercortisolemia in the brain and cardiovascular system
in recurrent MDD.
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